ArticlePediatric surgery international2025
Global, regional, and national burden for childhood and adolescent cancers from 1990 to 2021: from the Global Burden of Disease Study 2021.
Article in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Microplastics in early-onset carcinogenesis.Carcinogenesis · 2026Review
- Unsupervised Deep Representation Learning and Probabilistic Clustering for the Systems-Level Discovery of Germline Mutation Signatures in Pediatric Cancers.Biomedicines · 2026Article
- Neurosurgical management of paediatric central nervous system tumours in low, middle and high-income countries: a multi-centre, international, cross-sectional study.Neurosurgical review · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCancer is a major contributor to the global burden of disease, with children and adolescents being a population group that cannot be ignored. Our aim was to study the burden of cancer in children and adolescents (CAC) in 204 countries and territories from 1990 to 2021.
methodsGlobal age-standardized incidence rates (GASRs) and incidence trends for CAC for children aged 0-19 years were obtained from the Global Burden of Disease (GBD) database, stratified by 204 countries and territories from 1990 to 2021. In this submission, we present CAC prevalence, incidence, mortality, and DALYs globally, with separate analysis by SDI for difference in CAC by development levels. ASIR, ASPR, and EAPCS over time were used in the statistical analysis used in the study. Standardized crude rates were obtained by age group, sex, and ward, with t tests and analyses of variance used to compare differences in cancer incidence across regions. Prospective sources of risk were identified with emphasis on occupational carcinogens and indoor radon.
resultsIn the period between 1990 and 2021, global cases, deaths, and DALYs due to CAC totaled a decrease, while prevalence totaled an increase. However, both ASIR and ASPR tended to rise as SDI values were higher both in low-to-middle SDI areas. The evaluation also found that deaths from occupational carcinogens rose across the world, and deaths due to indoor radon, fell.
conclusionCAC is still a public health problem worldwide. Although age-standardized mortality and DALY decreased, they are still not equal and low-SDI countries had a higher burden. The bottleneck is that more substantial targeted interventions in low resource settings should be performed continually for reduction of the burden globally.
Indexed as
Identifiers
40560252What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.